BioDelivery Sciences

BioDelivery Sciences turns invisible pain into high-color art for gallery show
BioDelivery Sciences turns invisible pain into high-color art for gallery show
Fierce Pharma
BioDelivery Sciences
pain
invisible pain
Flag link:
$12.19 Million in Sales Expected for BioDelivery Sciences International, Inc. (BDSI) This Quarter
$12.19 Million in Sales Expected for BioDelivery Sciences International, Inc. (BDSI) This Quarter
Daily Political
BioDelivery Sciences
Flag link:
5 Small Biotechs Receive Shots in the Arm
5 Small Biotechs Receive Shots in the Arm
TheStreet.com
earnings
Synergy Pharmaceuticals
Omeros
BioDelivery Sciences
Heron Therapeutics
Dynavax
Flag link:
BioDelivery Sciences, Teva settle patent fight over opioid dependence treatment
BioDelivery Sciences, Teva settle patent fight over opioid dependence treatment
Drug Delivery Business News
BioDelivery Sciences
Teva Pharmaceutical
opioid addiction
opioids
Bunavail
generics
Flag link:
BioDelivery Sciences beats Q2 rev estimates, misses on EPS
BioDelivery Sciences beats Q2 rev estimates, misses on EPS
Drug Delivery Business News
BioDelivery Sciences
earnings
Flag link:
BioDelivery Sciences brings novel drug delivery tech to pain management, opioid addiction
BioDelivery Sciences brings novel drug delivery tech to pain management, opioid addiction
Drug Delivery Business News
BioDelivery Sciences
drug delivery
pain management
Flag link:
Why BioDelivery Sciences may benefit from U.S. push to reduce opiod abuse
Why BioDelivery Sciences may benefit from U.S. push to reduce opiod abuse
Bizjournals.com
BioDelivery Sciences
Bunvail
Belbuca
opioid addiction
Flag link:
Here's how Raleigh's BioDelivery plans to spend $50 million
Here's how Raleigh's BioDelivery plans to spend $50 million
Bizjournals.com
BioDelivery Sciences
R&D
Belbuca
Endo International
Flag link:
BioDelivery's opioid treatment wins FDA approval
BioDelivery's opioid treatment wins FDA approval
Yahoo/Reuters
FDA
painkillers
opioids
BioDelivery Sciences
Belbuca
Flag link:
Two Biotechs Worth A Look Ahead Of FDA Approvals
Two Biotechs Worth A Look Ahead Of FDA Approvals
Investopedia
FDA
BioDelivery Sciences
Belbuca
chronic pain
Spectrum Pharmaceuticals
Evomela
Flag link:
Analysts Bullish on BioDelivery Ahead of FDA Event
Analysts Bullish on BioDelivery Ahead of FDA Event
Investopedia
BioDelivery Sciences
FDA
Belbuca
chronic pain
Flag link:
BioDelivery: All Eyes On Belbuca
BioDelivery: All Eyes On Belbuca
Seeking Alpha
BioDelivery Sciences
Bunavail
Belbuca
Flag link:
With FDA approval, Raleigh's BioDelivery sees 10% stock bounce
With FDA approval, Raleigh's BioDelivery sees 10% stock bounce
Bizjournals.com
FDA
BioDelivery Sciences
Onsolis
cancer pain
breakthrough pain
Flag link:
Raleigh's BioDelivery hires former Salix sales workers
Raleigh's BioDelivery hires former Salix sales workers
Bizjournals.com
BioDelivery Sciences
Salix
hirings
Flag link:
5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015
5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015
24/7 Wall St
Cerus
Nektar
Idera Pharmaceuticals
BioDelivery Sciences
Biocryst
Flag link:
BioDelivery tanks as its pain gel comes up short in Phase III
BioDelivery tanks as its pain gel comes up short in Phase III
Fierce Biotech
BioDelivery Sciences
clonidine gel
painkillers
Flag link:
FDA agrees to review Endo Pharmaceutical's inside-the-cheek pain drug
FDA agrees to review Endo Pharmaceutical's inside-the-cheek pain drug
Fierce Drug Delivery
Endo Pharmaceutical
BioDelivery Sciences
pain management
BioErodible MucoAdhesive
Flag link:
How Raleigh's BioDelivery will use $10M it got from partner on pain drug
How Raleigh's BioDelivery will use $10M it got from partner on pain drug
Bizjournals.com
BioDelivery Sciences
Belbuca
Endo Health Solutions
Flag link:
BioDelivery Sciences to relaunch cancer pain medication; shares bounce
BioDelivery Sciences to relaunch cancer pain medication; shares bounce
Bizjournals.com
BioDelivery Sciences
Onsolis
Meda
cancer pain
Flag link:
For this drug developer, 2014 was 'best year in company history'
For this drug developer, 2014 was 'best year in company history'
Bizjournals.com
BioDelivery Sciences
Buprenorphine HCl Buccal Film
chronic pain
Endo Health Solutions
Flag link:

Pages